Overexpression of oxidored-nitro domain containing protein 1 inhibits human nasopharyngeal carcinoma and cervical cancer cell proliferation and induces apoptosis: Involvement of mitochondrial apoptotic pathways

Ouyang,Jue; Wu,Minghua; Huang,Chen; Cao,Li; Li,Guiyuan

doi:10.3892/or.2012.2101

Overexpression of oxidored-nitro domain containing protein 1 inhibits human nasopharyngeal carcinoma and cervical cancer cell proliferation and induces apoptosis: Involvement of mitochondrial apoptotic pathways

Authors:
- Jue Ouyang
- Minghua Wu
- Chen Huang
- Li Cao
- Guiyuan Li
View Affiliations

Affiliations: Cancer Research Institute, Disease Genome Research Center, Central South University; Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education; Key Laboratory of Carcinogenesis, Ministry of Health, Changsha, Hunan, P.R. China, Medical Research Center, Peking University Third Hospital, Beijing, P.R. China
Published online on: October 23, 2012 https://doi.org/10.3892/or.2012.2101
Pages: 79-86

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Oxidored-nitro domain containing protein 1 (NOR1) is a novel member of the nitroreductase family that was first isolated as a tumor suppressor gene from human nasopharyngeal carcinoma (NPC). However, the role of NOR1 gene dysfunction in human cancers has not been addressed. We analyzed the expression of NOR1 in various human cancer and benign tissue specimens and found significant downregulation in nine types of cancer compared with corresponding non-tumor tissues. The recombinant expression vector pCDNA3.1-myc-his-NOR1 was constructed and transfected into human NPC 6-10B nasopharyngeal cancer and HeLa cervical cancer (CCA) cells. We found that stable NOR1 overexpression resulted in suppression of 6-10B and HeLa cell proliferation and led to S phase cell cycle arrest. In addition, NOR1 upregulation enhanced apoptosis in pCDNA3.1-myc-his-NOR1 stably transfected cells, and it also altered the expression of proteins involved in the mitochondria-dependent apoptotic pathway. Furthermore, we also found that the NOR1 protein is a cytoplasmic protein that is partially localized in the mitochondria and endoplasmic reticulum. Therefore, NOR1 is an important tumor suppressor gene associated with NPC and CCA and may play antitumor roles by inhibiting proliferation, preventing colony formation, and promoting the apoptosis of tumor cells via the mitochondrial-dependent apoptotic pathway. However, the precise mechanism behind the NOR1 antitumor effects needs to be investigated further.

View Figures

View References

1	Nie X, Zhang B, Li X, et al: Cloning, expression, and mutation analysis of NOR1, a novel human gene down-regulated in HNE1 nasopharyngeal carcinoma cell line. J Cancer Res Clin Oncol. 129:410–414. 2003. View Article : Google Scholar : PubMed/NCBI
2	Xiang B, Yi M, Wang L, et al: Preparation of polyclonal antibody specific for NOR1 and detection of its expression pattern in human tissues and nasopharyngeal carcinoma. Acta Biochim Biophys Sin. 41:754–762. 2009. View Article : Google Scholar
3	Li W, Li X, Wang W, et al: NOR1 is an HSF1- and NRF1-regulated putative tumor suppressor inactivated by promoter hypermethylation in nasopharyngeal carcinoma. Carcinogenesis. 32:1305–1314. 2011. View Article : Google Scholar : PubMed/NCBI
4	Kroeger H, Jelinek J, Estecio MR, et al: Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse. Blood. 112:1366–1373. 2008. View Article : Google Scholar : PubMed/NCBI
5	Calmels S, Ohshima H, Rosenkranz H, McCoy E and Bartsch H: Biochemical studies on the catalysis of nitrosation by bacteria. Carcinogenesis. 8:1085–1088. 1987. View Article : Google Scholar : PubMed/NCBI
6	Reznik G, Mohr U and Kruger FW: Carcinogenic effects of Di-n-propylnitrosamine, beta-hydroxypropyl-n-propylnitrosamine, and methyl-n-propylnitrosamine on Sprague-Dawlay rats. J Natl Cancer Inst. 54:937–943. 1975.PubMed/NCBI
7	Lijinsky W and Taylor HW: Carcinogenicity of methylated nitrosopiperidines. Int J Cancer. 16:318–322. 1975. View Article : Google Scholar
8	Chang ET and Adami HO: The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 15:1765–1777. 2006. View Article : Google Scholar : PubMed/NCBI
9	Lo KW, To KF and Huang DP: Focus on nasopharyngeal carcinoma. Cancer Cell. 5:423–428. 2004. View Article : Google Scholar : PubMed/NCBI
10	Lin YP, Nicholas K, Ball FR, McLaughlin B and Bishai FR: Detection of Norwalk-like virus and specific antibody by immune-electron microscopy with colloidal gold immune complexes. J Virol Methods. 35:237–253. 1991. View Article : Google Scholar : PubMed/NCBI
11	Yan J, Fang Y and Liang Q: Frequent chromosomal gain of 4q and loss of 1p in primary nasopharyngeal carcinoma. Zhonghua Zhong Liu Za Zhi. 23:208–210. 2001.(In Chinese).
12	Fang Y, Guan X, Guo Y, et al: Analysis of genetic alterations in primary nasopharyngeal carcinoma by comparative genomic hybridization. Genes Chromosomes Cancer. 30:254–260. 2001. View Article : Google Scholar : PubMed/NCBI
13	Shao JY, Wang HY, Huang XM, et al: Genome-wide allelotype analysis of sporadic primary nasopharyngeal carcinoma from southern China. Int J Oncol. 17:1267–1275. 2000.PubMed/NCBI
14	Lo KW, Teo PM, Hui AB, et al: High resolution allelotype of microdissected primary nasopharyngeal carcinoma. Cancer Res. 60:3348–3353. 2000.PubMed/NCBI
15	Gadji M, Fortin D, Tsanaclis AM and Drouin R: Is the 1p/19q deletion a diagnostic marker of oligodendrogliomas? Cancer Genet Cytogenet. 194:12–22. 2009. View Article : Google Scholar : PubMed/NCBI
16	Tews B, Roerig P, Hartmann C, et al: Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumours with allelic losses on 1p and 19q. Oncogene. 26:5010–5016. 2007. View Article : Google Scholar : PubMed/NCBI
17	Chunder N, Mandal S, Basu D, Roy A, Roychoudhury S and Panda CK: Deletion mapping of chromosome 1 in early onset and late onset breast tumors - a comparative study in eastern India. Pathol Res Pract. 199:313–321. 2003. View Article : Google Scholar : PubMed/NCBI
18	Jung JY and Kim WJ: Involvement of mitochondrial- and Fas-mediated dual mechanism in CoCl₂-induced apoptosis of rat PC12 cells. Neurosci Lett. 371:85–90. 2004. View Article : Google Scholar : PubMed/NCBI
19	Gross A, McDonnell JM and Korsmeyer SJ: BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13:1899–1911. 1999. View Article : Google Scholar : PubMed/NCBI
20	Kruse JP and Gu W: Modes of p53 regulation. Cell. 137:609–622. 2009. View Article : Google Scholar
21	Wang CY, Mayo MW, Korneluk RG, Goeddel DV and Baldwin AS Jr: NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science. 281:1680–1683. 1998. View Article : Google Scholar : PubMed/NCBI
22	Kucharczak J, Simmons MJ, Fan Y and Gelinas C: To be, or not to be: NF-kappaB is the answer - role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene. 22:8961–8982. 2003. View Article : Google Scholar : PubMed/NCBI
23	Stoffel A and Levine AJ: Actvation of NF-kappaB by the API2/MALT1 fusions inhibits p53 dependant but not FAS induced apoptosis: a directional link between NF-kappaB and p53. Cell Cycle. 3:1017–1020. 2004. View Article : Google Scholar : PubMed/NCBI
24	Yin Y, Chen W, Tang C, et al: NF-kappaB, JNK and p53 pathways are involved in tubeimoside-1-induced apoptosis in HepG2 cells with oxidative stress and G(2)/M cell cycle arrest. Food Chem Toxicol. 49:3046–3054. 2011. View Article : Google Scholar : PubMed/NCBI
25	Maldonado ME, Bousserouel S, Gosse F, Lobstein A and Raul F: Implication of NF-kappaB and p53 in the expression of TRAIL-death receptors and apoptosis by apple procyanidins in human metastatic SW620 cells. Biomedica. 30:577–586. 2010. View Article : Google Scholar : PubMed/NCBI
26	Pratheeshkumar P, Sheeja K and Kuttan G: Andrographolide induces apoptosis in B16F-10 melanoma cells by inhibiting NF-kappaB-mediated bcl-2 activation and modulating p53-induced caspase-3 gene expression. Immunopharmacol Immunotoxicol. 34:143–151. 2012. View Article : Google Scholar : PubMed/NCBI